Insider trades
Burke Steven Keith, Chief Officer of Akebia Therapeutics AKBA, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $94K. The latest trade was on 02/02.
Burke Steven Keith
SVP, Chief Medical Officer
- Company
- Akebia Therapeutics AKBA
- First filing
- 23/02/02
- Trades
- 23 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- −$94K
- Last trade
- 02/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AKBA | Open-market sale10b5-1 plan | 02/02 | 02/04 | 67,658 sh3 trades | $1.39avg. | $94,044.62 | −6.7% |
| Open-market sale10b5-1 plan | 25/03/03 | 25/03/04 | 7,144 sh | $1.83 | $13,073.52 | −0.9% | |
AKBA | Open-market sale10b5-1 plan | 25/02/03 | 25/02/04 | 50,506 sh2 trades | $2.10avg. | $106,062.6 | −5.8% |
| Open-market sale | 23/08/25 | 24/05/09 | 27,000 sh | $1.15 | $31,050 | −3.9% | |
| Open-market sale | 24/02/29 | 24/03/01 | 7,169 sh | $1.58 | $11,327.02 | −1.0% | |
| Open-market sale10b5-1 plan | 24/02/27 | 24/02/29 | 8,367 sh | $1.52 | $12,717.84 | −1.2% | |
| Open-market sale | 24/02/01 | 24/02/02 | 24,311 sh | $1.68 | $40,842.48 | −3.3% | |
| Open-market sale | 23/05/16 | 23/05/18 | 63,567 sh | $1.07 | $68,016.69 | −10.7% | |
AKBA | Open-market sale | 23/03/01 | 23/03/03 | 14,123 sh3 trades | $0.88avg. | $12,428.24 | −2.3% |
| Open-market sale | 23/02/27 | 23/03/01 | 7,539 sh | $0.81 | $6,106.59 | −1.2% |